Zhidong Gao
Overview
Explore the profile of Zhidong Gao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
419
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luo C, Zhang R, Guo R, Wu L, Xue T, He Y, et al.
Immunity
. 2025 Mar;
58(3):745-765.e9.
PMID: 40023158
Many cancer drugs that target cancer cell pathways also impair the immune system. We developed a computational target discovery platform to enable examination of both cancer and immune cells so...
2.
Ma R, Li G, Ye Y, Liang L, Wang C, Zhou H, et al.
Transl Oncol
. 2025 Feb;
53:102279.
PMID: 39929063
Introduction: Pseudomyxoma Peritonei (PMP) is an extremely rare disease characterized by progressive accumulation of mucinous ascites and implants in the peritoneum. We investigated the prognostic value for response to cytoreductive...
3.
Yang Y, Pang K, Lin G, Liu X, Gao J, Zhou J, et al.
Nat Med
. 2025 Jan;
31(2):449-456.
PMID: 39762418
Radiotherapy displays unique antitumor synergism with immune checkpoint inhibitors, which is indicated by high pathological complete response (pCR) rates from single-arm trials of locally advanced rectal cancer (LARC). Here we...
4.
Wang S, Hou S, Jiang S, Wang C, Zhang P, Ye Y, et al.
Front Immunol
. 2025 Jan;
15:1514613.
PMID: 39749343
Background: An increasing body of evidence indicates that dysregulation of liquid-liquid phase separation (LLPS) in cellular processes is implicated in the development of diverse tumors. Nevertheless, the association between LLPS...
5.
Xiong N, Du Y, Huang C, Yan Q, Zhao L, Yang C, et al.
Adv Sci (Weinh)
. 2024 Dec;
12(7):e2411740.
PMID: 39716927
Liver metastasis is the primary factor contributing to unfavorable prognosis in colorectal cancer (CRC). Although N-glycosylation is implicated in metastasis, there is a notable paucity of comprehensive studies addressing the...
6.
Hu B, Ye Y, Gao Z
Gastroenterol Rep (Oxf)
. 2024 Nov;
12:goae095.
PMID: 39588533
Background: The liver is the most common site of gastrointestinal stromal tumor (GIST) metastasis. Most patients who develop metastases gradually develop multiline drug resistance during long-term systematic treatment. We aimed...
7.
Gao Z, Shen Z, Wang S, Ye Y
Cancer Pathog Ther
. 2024 Oct;
2(4):217-218.
PMID: 39371098
No abstract available.
8.
Jia X, Xiao Y, Zhang H, Li J, Lv S, Zhang Y, et al.
Eur Radiol
. 2024 Sep;
PMID: 39349725
Objectives: To investigate the correlation of the mitotic index (MI) of 1-5 cm gastric gastrointestinal stromal tumors (gGISTs) with CT-identified morphological and first-order radiomics features, incorporating subgroup analysis based on...
9.
Gan L, Yang C, Zhao L, Wang S, Ye Y, Gao Z
Clin Transl Oncol
. 2024 Jul;
27(2):549-566.
PMID: 39009862
Background: Endoplasmic reticulum aminopeptidase 1 (ERAP1) is an emerging pharmacological target in cancer immunotherapy. This study was set out to examine the expression profiles and implications for prognosis and immunotherapy...
10.
Hu B, Xie Q, Ye Y, Gao Z
Asian J Surg
. 2024 Jun;
47(11):4849-4850.
PMID: 38845314
No abstract available.